In Vitro and Other Replacement Approaches Alan M. Goldberg Ph.D.,/ James Yager Ph.D., Johns Hopkins University, Bloomberg School of Public Health
Opening Remarks
Replacement Reduction and Refinement Concept of Replacement Alternatives Organizations for Validation of Alternative Methods Systems for Testing Physiologically Based Pharmacokinetic (PBPK) Modeling Insulin / Anti-Cancer Agent Screening The Use of Reconstituted Tissue Equivalents Advantages / Disadvantages of In Vitro Systems
Conclusions
Study Questions
Resources (reference articles/books)
